Avenzoar Pharmaceuticals
PrivateLast Round
Seed
Oct 31, 2019
Total Funding Raised
$3.64M
Company Overview
Avenzoar Pharmaceuticals is a biotechnology company that develops small molecule therapeutics targeting cancer metastasis and drug resistance mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avenzoar Pharmaceuticals Comparables
Compare Avenzoar Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agastiya Biotech | 82% | |
| Persevere Therapeutics | 81% | |
| Pacylex Pharmaceuticals | 71% | |
Avenzoar Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 31, 2019 | ||||
| Grant | Sep 20, 2019 |
Avenzoar Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 31, 2019
$525K raised in seed funding.
- Sep 20, 2019
$212K grant received from the National Cancer Institute.
Avenzoar Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avenzoar Pharmaceuticals's valuation, stock price, and market status.